NKTR-181 BID tablets

DRUG2 trials

Sponsors

Nektar Therapeutics

Conditions

Chronic PainLow Back Pain

Phase 3

Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain

CompletedNCT02362672

Nektar TherapeuticsChronic Pain, Low Back Pain

Start: 2015-03-11End: 2017-02-28Updated: 2020-09-16

Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain

CompletedNCT02367820

Nektar TherapeuticsChronic Pain, Low Back Pain

Start: 2015-04-14End: 2018-01-31Updated: 2021-06-22